TY - JOUR AB - Subsequently to the publication of this paper, the authors have realized that the name of the sixth listed author, José Díaz‑Chávez, was spelt incorrectly (it appeared as “José Chávez‑Díaz” in print). The corrected author list, as it should have appeared in the paper, is shown above. The authors regret that the name of the sixth author on the paper was spelt incorrectly, and apologize to the readers for any inconvenience caused. [the original article was published in Oncology Letters 18: 6909‑6916, 2019; DOI: 10.3892/ol.2019.11008] AD - Basic Research Division, National Cancer Institute, Mexico City 14080, Mexico AU - Schcolnik‑Cabrera,Alejandro AU - Dominguez‑Gómez,Guadalupe AU - Chávez‑Blanco,Alma AU - Ramírez‑Yautentzi,Marisol AU - Morales‑Bárcenas,Rocío AU - Díaz‑Chávez,José AU - Taja‑Chayeb,Lucía AU - Dueñas‑González,Alfonso DA - 2020/03/01 DO - 10.3892/ol.2020.11303 EP - 2071 IS - 3 JO - Oncol Lett KW - cancer metabolism chemokines small interfering RNA blockade lonidamine 6‑Diazo‑5‑oxo‑L‑norleucine orlistat PY - 2020 SN - 1792-1074 1792-1082 SP - 2071 ST - [Corrigendum] A combination of inhibitors of glycolysis, glutaminolysis and de novo fatty acid synthesis decrease the expression of chemokines in human colon cancer cells T2 - Oncology Letters TI - [Corrigendum] A combination of inhibitors of glycolysis, glutaminolysis and de novo fatty acid synthesis decrease the expression of chemokines in human colon cancer cells UR - https://doi.org/10.3892/ol.2020.11303 VL - 19 ER -